Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials Sponsored by Douglas W. Johnson MD, FACR
Total 0 results
Nothing found
Sponsors and Collaborators
Van Boven, Robert W., M.D.
Xiao-Ming Mao
Genuv Inc.
Egyptian Russian University
Only For Children Pharmaceuticals
Marcus Vinícius Guimarães de Lacerda
Jia Liu
Klinikum Bad Woerishofen
The People's Hospital of Guangxi Zhang Autonomous Region
Friedrich Miescher Institute for Biomedical Research (FMI)
Hoersholm Hospital
Sahar Salehi
Liming Cheng
Royal Hobart Hospital Research Foundation (funding source)
Hopeful Aging
Kuwait University
Pancreatic Cancer UK
Biorobotic Institute Scuola Superiore sant'Anna Pisa
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Kerstyn C. Zalesin, M.D.
View Full List
Medical Conditions
Stage II Vulvar Cancer
High Perinatal Mortality
Caffeine Dosage
Secondary Hypertension to Endocrine Disorders
Airway Obstruction
Smith-Lemli-Opitz Syndrome
Role of Vitamin D in IVF for Better Outcome
Pulmonary Invasive Aspergillosis
Stereotype-threat
Raynaud Secondary to Other Autoimmune Disease
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Global Health
Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
Advanced Gastric Cancer With Serosal Invasion
Enlarged Uterus
EHMT1
Gait Variability; Elders; Fall; Re-education
Pancytopenia Due to Chemotherapy
Autologous Haematopoietic Stem Cell Transplant
Urinary Tract Carcinoma
View Full List
Drug Interventions
Insulin
Cytarabine ARA-C
Polyethylene glycol 3350
Bortezomib/dexamethasone
Indoximod
Methotrexate
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
SERETIDE Diskus
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Oxycodone, fentanyl
Ruxolitinib
Enzalutamide, Abiraterone
Mupirocin Calcium
Topotecan
Flibanserin 100 mg dose every evening
Epimedium Prenylflavonoids Extract
Atezolizumab
Cetrorelix 78 mg + 78 mg
Lamivudine
PF-00868554
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Armenia
Contract Research Organizations in Ethiopia
Contract Research Organizations in France
Contract Research Organizations in Jamaica
Contract Research Organizations in Japan
Contract Research Organizations in Kosovo
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Paraguay
Contract Research Organizations in United Kingdom
Contract Research Organizations in Venezuela
Contract Research Organizations in Zambia
CRO list by country
CROs in Morocco
"Gaya Pharma" by Morocco Africa Health & Pharma (MAHP)
MCT
SGS
4Clinics
All CROs in Morocco
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe